Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 1257044-40-8
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
1257044-40-8 |
Appearance:: |
Yellow Solid |
Molecular Formula:: |
C45H50ClN7O7S |
Molecular Weight:: |
868.43900 |
EINECS NO:: |
820-130-9 |
MDL NO:: |
MFCD357044408 |
CAS NO:: |
1257044-40-8 |
Appearance:: |
Yellow Solid |
Molecular Formula:: |
C45H50ClN7O7S |
Molecular Weight:: |
868.43900 |
EINECS NO:: |
820-130-9 |
MDL NO:: |
MFCD357044408 |
Product Description:
Product Name: venetoclax CAS NO: 1257044-40-8
Synonyms:
GDC-0199;
CS-1155;
RG7601;
Chemical & Physical Properties:
Appearance: Yellow solid
Assay: ≥99.0%
Density: 1.340±0.06 g/cm3 (Predicted)
Boiling point: 697.6±55.0℃(Predicted)
Storage: 3 years -20℃
Solubility: Insoluble (6.3E-6 g/L) (25℃)
Refractive index: 1.644
Venetoclax (INN, trade name Venclexta ven-KLEKS-tuh, previously known as GDC-0199, ABT-199, and RG7601) is a small molecule oral drug being investigated to treat chronic lymphocytic leukemia (CLL). In 2015, the United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to venetoclax for patients with CLL who have relapsed or have been refractory to previous treatment and have the 17p deletion genetic mutation.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
